Xuefeng Kan

1.1k total citations
61 papers, 751 citations indexed

About

Xuefeng Kan is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Xuefeng Kan has authored 61 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hepatology, 14 papers in Pulmonary and Respiratory Medicine and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Xuefeng Kan's work include Hepatocellular Carcinoma Treatment and Prognosis (32 papers), Cancer Mechanisms and Therapy (12 papers) and Liver Disease and Transplantation (8 papers). Xuefeng Kan is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (32 papers), Cancer Mechanisms and Therapy (12 papers) and Liver Disease and Transplantation (8 papers). Xuefeng Kan collaborates with scholars based in China, United States and Canada. Xuefeng Kan's co-authors include Chuansheng Zheng, Bin Xiong, Yanqiao Ren, Bin Liang, Yanyan Cao, Tao Ouyang, Tao Sun, Lei Chen, Guofeng Zhou and Kun Qian and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Physical review. B, Condensed matter.

In The Last Decade

Xuefeng Kan

55 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuefeng Kan China	16	280	175	162	117	107	61	751
Zhongzhen Su China	18	249 0.9×	129 0.7×	211 1.3×	133 1.1×	193 1.8×	77	912
Dewei Li China	18	249 0.9×	100 0.6×	208 1.3×	136 1.2×	222 2.1×	78	900
Wuwei Yang China	11	206 0.7×	136 0.8×	116 0.7×	124 1.1×	108 1.0×	21	614
Guojun Qian China	15	554 2.0×	200 1.1×	115 0.7×	144 1.2×	339 3.2×	38	931
Mengtao Zhou China	21	181 0.6×	112 0.6×	389 2.4×	259 2.2×	160 1.5×	45	927
Min Du China	13	177 0.6×	83 0.5×	111 0.7×	146 1.2×	65 0.6×	37	550
Kuan Hu China	16	125 0.4×	166 0.9×	414 2.6×	120 1.0×	92 0.9×	53	769
Caecilia Sukowati Italy	16	222 0.8×	78 0.4×	429 2.6×	227 1.9×	197 1.8×	47	848
Manon Buijs United States	22	487 1.7×	162 0.9×	336 2.1×	225 1.9×	206 1.9×	33	1.2k

Countries citing papers authored by Xuefeng Kan

Since Specialization

Citations

This map shows the geographic impact of Xuefeng Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefeng Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefeng Kan more than expected).

Fields of papers citing papers by Xuefeng Kan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefeng Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefeng Kan. The network helps show where Xuefeng Kan may publish in the future.

Co-authorship network of co-authors of Xuefeng Kan

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefeng Kan. A scholar is included among the top collaborators of Xuefeng Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefeng Kan. Xuefeng Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Guilin, Yanqiao Ren, Jiayun Liu, et al.. (2025). Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis. Journal of Hepatocellular Carcinoma. Volume 12. 15–27.

Zhang, Guilin, et al.. (2025). Clinical outcomes of carotid artery stenting with open- versus closed-cell stents. Journal of NeuroInterventional Surgery. 18(3). 614–619.

Guo, Yusheng, Yao Pan, Jiayu Wan, et al.. (2024). Prognosis stratification of cancer patients treated with immune checkpoint inhibitors through lung immune prognostic index: a meta-analysis and systematic review. BMC Cancer. 24(1). 523–523. 3 indexed citations

Sun, Tao, Jiayun Liu, Yanyan Cao, et al.. (2024). Radiofrequency hyperthermia enhances the effect of OK-432 for Hepatocellular carcinoma by activating of TLR4-cGAS-STING pathway. International Immunopharmacology. 130. 111769–111769. 7 indexed citations

Cao, Yanyan, Tao Sun, Bo Sun, et al.. (2023). Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation. Journal of Nanobiotechnology. 21(1). 404–404. 14 indexed citations

Kan, Xuefeng, et al.. (2022). Application of Intravoxel Incoherent Motion in the Evaluation of Hepatocellular Carcinoma after Transarterial Chemoembolization. Current Oncology. 29(12). 9855–9866. 1 indexed citations

Sun, Tao, Lei Chen, Xuefeng Kan, et al.. (2022). A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Journal of Oncology. 2022. 1–10. 3 indexed citations

Liu, Ziyi, Xuefeng Kan, Lijie Zhang, et al.. (2022). Transarterial Chemoembolization Combined with Apatinib for Treatment of Advanced Hepatocellular Carcinoma: Analysis of Survival and Prognostic Factors. Current Medical Science. 42(5). 1015–1021. 3 indexed citations

Kan, Xuefeng, Yanqiao Ren, Xin Li, et al.. (2021). Value of 18F-FDG PET/MR Imaging in the Early Evaluation of Treatment Response following Radiofrequency Ablation of Liver Cancer in a Rabbit Model. Journal of Vascular and Interventional Radiology. 33(4). 452–459.e3. 1 indexed citations

10.

Cao, Yanyan, Tao Ouyang, Xuefeng Kan, et al.. (2021). Efficacy of apatinib in patients with sorafenib–transarterial chemoembolization refractory hepatocellular carcinoma: a retrospective study. Hepatology International. 15(5). 1268–1277. 8 indexed citations

11.

Ren, Yanqiao, Lei Chen, Tao Sun, et al.. (2021). Combined Ultrasound and CT-Guided Iodine-125 Seeds Implantation for Treatment of Residual Hepatocellular Carcinoma Located at Complex Sites After Transcatheter Arterial Chemoembolization. Frontiers in Oncology. 11. 582544–582544. 11 indexed citations

12.

Cao, Yanyan, Tao Sun, Xiaopeng Guo, et al.. (2021). Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study. Frontiers in Oncology. 11. 673378–673378. 10 indexed citations

13.

Liu, Fang, Hui Guo, Dong Xu, et al.. (2020). Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study. BMC Gastroenterology. 20(1). 30–30. 20 indexed citations

14.

Chen, Lei, Xuefeng Kan, Tao Sun, et al.. (2020). Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma. BMC Gastroenterology. 20(1). 205–205. 13 indexed citations

15.

Sun, Tao, Yanqiao Ren, Xuefeng Kan, et al.. (2020). Advanced Hepatocellular Carcinoma With Hepatic Arterioportal Shunts: Combination Treatment of Transarterial Chemoembolization With Apatinib. Frontiers in Molecular Biosciences. 7. 607520–607520. 8 indexed citations

16.

Ren, Yanqiao, Yanyan Cao, Hong Ma, et al.. (2019). Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study. BMC Cancer. 19(1). 983–983. 51 indexed citations

17.

Kan, Xuefeng, Huimin Liang, Bin Xiong, et al.. (2019). Comparison of mid-term outcomes of endovascular repair and medical management in patients with acute uncomplicated type B aortic dissection. Journal of Thoracic and Cardiovascular Surgery. 162(1). 26–36.e1. 40 indexed citations

18.

Kan, Xuefeng, Yong Wang, Ping Han, et al.. (2019). <p>Combined ultrasound/computed tomography guidance in percutaneous radiofrequency ablation after transarterial chemoembolization for hepatocellular carcinoma in the hepatic dome</p>. Cancer Management and Research. Volume 11. 7751–7757. 12 indexed citations

19.

Kan, Xuefeng, Yong Wang, Bin Xiong, et al.. (2016). Radiofrequency ablation combined with transarterial chemoembolization for liver metastases from gastrointestinal cancers. Journal of Huazhong University of Science and Technology [Medical Sciences]. 36(2). 200–204. 5 indexed citations

20.

Kan, Xuefeng, Bo Wang, Heshui Wu, et al.. (2014). miR-152 suppresses gastric cancer cell proliferation and motility by targeting CD151. Tumor Biology. 35(11). 11367–11373. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact